These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29212355)

  • 21. Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL.
    Wehrle-Wieland E; Affolter K; Goldenberger D; Tschudin Sutter S; Halter J; Passweg J; Tamm M; Khanna N; Stolz D
    Transpl Infect Dis; 2018 Oct; 20(5):e12953. PubMed ID: 29896857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of the updated European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and the Mycoses Study Group Education and Research Consortium computed tomography criteria of invasive pulmonary aspergillosis in hematological malignancies.
    Hałaburda-Rola M; Dzieciątkowski T; Górka M; Rowiński O; Grabowska-Derlatka L
    Hematology; 2021 Dec; 26(1):398-407. PubMed ID: 34057050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging studies for diagnosing invasive fungal pneumonia in immunocompromised patients.
    Marom EM; Kontoyiannis DP
    Curr Opin Infect Dis; 2011 Aug; 24(4):309-14. PubMed ID: 21673574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.
    Maertens J; Selleslag D; Heinz WJ; Saulay M; Rahav G; Giladi M; Aoun M; Kovanda L; Kaufhold A; Engelhardt M; Cornely OA; Herbrecht R; Ullmann AJ
    Mycoses; 2018 Nov; 61(11):868-876. PubMed ID: 30035825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yield of diagnostic procedures for invasive fungal infections in neutropenic febrile patients with chest computed tomography abnormalities.
    Ho DY; Lin M; Schaenman J; Rosso F; Leung AN; Coutre SE; Sista RR; Montoya JG
    Mycoses; 2011 Jan; 54(1):59-70. PubMed ID: 19793207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease.
    Cornely OA; Maertens J; Bresnik M; Ebrahimi R; Dellow E; Herbrecht R; Donnelly JP
    Mycoses; 2011 Sep; 54(5):e449-55. PubMed ID: 21039936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.
    Caillot D; Casasnovas O; Bernard A; Couaillier JF; Durand C; Cuisenier B; Solary E; Piard F; Petrella T; Bonnin A; Couillault G; Dumas M; Guy H
    J Clin Oncol; 1997 Jan; 15(1):139-47. PubMed ID: 8996135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary aspergillosis in immunocompetent patients without air-meniscus sign and underlying lung disease: CT findings and histopathologic features.
    Yoon SH; Park CM; Goo JM; Lee HJ
    Acta Radiol; 2011 Sep; 52(7):756-61. PubMed ID: 21596796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings.
    Nam BD; Kim TJ; Lee KS; Kim TS; Han J; Chung MJ
    Eur Radiol; 2018 Feb; 28(2):788-795. PubMed ID: 28812135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The typical radiological findings and course of invasive pulmonary aspergillosis in the immunosuppressed patient].
    Leutner C; Strunk H; Müller-Miny H; Ewig S; Glasmacher A; Losem C; Molitor E; Schild HH
    Rofo; 1997 Jul; 167(1):24-31. PubMed ID: 9289038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts.
    Georgiadou SP; Sipsas NV; Marom EM; Kontoyiannis DP
    Clin Infect Dis; 2011 May; 52(9):1144-55. PubMed ID: 21467021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary cryptococcosis: comparison of CT findings in immunocompetent and immunocompromised patients.
    Xie LX; Chen YS; Liu SY; Shi YX
    Acta Radiol; 2015 Apr; 56(4):447-53. PubMed ID: 24757183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
    Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
    J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facilitating surveillance of pulmonary invasive mold diseases in patients with haematological malignancies by screening computed tomography reports using natural language processing.
    Ananda-Rajah MR; Martinez D; Slavin MA; Cavedon L; Dooley M; Cheng A; Thursky KA
    PLoS One; 2014; 9(9):e107797. PubMed ID: 25250675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
    Prattes J; Lackner M; Eigl S; Reischies F; Raggam RB; Koidl C; Flick H; Wurm R; Palfner M; Wölfler A; Neumeister P; Thornton CR; Krause R; Lass-Flörl C; Hoenigl M
    Mycoses; 2015 Aug; 58(8):461-9. PubMed ID: 26103209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.
    Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP
    J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary pulmonary cryptococcosis: evaluation of CT characteristics in 26 immunocompetent Chinese patients.
    Qu Y; Liu G; Ghimire P; Liao M; Shi H; Yang G; Xu L; Wang G
    Acta Radiol; 2012 Jul; 53(6):668-74. PubMed ID: 22798384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The initial CT findings in patients suffering from invasive pulmonary aspergillosis].
    Xu SC; Dong XN; Baihetinisha T; Deng LJ; Guo XH; Sang XH; Qiu LH; Ren BX
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Apr; 25(4):229-32. PubMed ID: 23660100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies.
    Candoni A; Mestroni R; Damiani D; Tiribelli M; Michelutti A; Silvestri F; Castelli M; Viale P; Fanin R
    Eur J Haematol; 2005 Sep; 75(3):227-33. PubMed ID: 16104879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies.
    Nosari A; Anghilieri M; Carrafiello G; Guffanti C; Marbello L; Montillo M; Muti G; Ribera S; Vanzulli A; Nichelatti M; Morra E
    Haematologica; 2003 Dec; 88(12):1405-9. PubMed ID: 14687995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.